• Svenska
  • English
Toleranzia - Logotype
  • Start
  • About us
    • Operations
    • Board of Directors
    • Management
    • Team
    • Collaboration
    • Career
  • Technology
    • Tolerogens
  • Program
    • Autoimmune disease
    • Rare disease
    • Myasthenia Gravis
    • SME Instrument
    • Pipeline
  • News
    • All press releases
    • Recent and Upcoming Events
    • Media
  • Investors
    • Rights Issue 2023
    • Reports
    • Corporate Governance
    • Share information
    • Investor Relations
  • Contact
  • Share price:
  • Latest: (SEK)  
  • High: (SEK)  
  • Nasdaq
  • Toleranzia - Twitter

News

  • All press releases
  • Recent and Upcoming Events
  • Media

Press releases

6 May - 2025

Notice of Annual General Meeting in Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to the...

4 April - 2025

Notice of Extraordinary General Meeting in Toleranzia AB

The shareholders of Toleranzia AB, reg. no. 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to...

20 May - 2024

Notice of Annual General Meeting in Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to the...

9 May - 2023

Notice of Annual General Meeting of Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to attend...

4 May - 2022

Notice of Annual General Meeting of Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to attend...

10 August - 2021

Notice of extraordinary general meeting of Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), org.nr 556877-2866 ("Toleranzia" or the "Company"), are hereby convened to...

Subscribe to
Toleranzia’s news here

Toleranzia AB

Arvid Wallgrens backe 20, 8th floor
SE-413 46 Göteborg, Sweden

More contact info

© 2015-2025 Toleranzia AB | All rights reserved

plucera webbyrå

  • Start
  • About us
    ▼
    • Operations
    • Board of Directors
    • Management
    • Team
    • Collaboration
    • Career
  • Technology
    ▼
    • Tolerogens
  • Program
    ▼
    • Autoimmune disease
    • Rare disease
    • Myasthenia Gravis
    • SME Instrument
    • Pipeline
  • News
    ▼
    • All press releases
    • Recent and Upcoming Events
    • Media
  • Investors
    ▼
    • Rights Issue 2023
    • Reports
    • Corporate Governance
    • Share information
    • Investor Relations
  • Contact
Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida. Om du fortsätter att använda den här webbplatsen kommer vi att anta att du godkänner detta. Ok